معرفی
Michael Sterr is a Group Leader of the Single-Cell Genomics Unit at the Institute of Diabetes and Regeneration Research (IDR), Helmholtz Munich. His research leverages single-cell genomics to unravel the developmental programs of pancreatic and intestinal endocrine cells, aiming to improve diabetes therapy.
His educational background includes:
- Bioengineering and Biology studies in Munich.
- PhD (2013-2019) at Helmholtz Zentrum München under Prof. Heiko Lickert, focusing on "Transcriptional Regulation of Endocrine Cell Formation and Function in Pancreas and Intestine".
- Postdoctoral research (2019-2021) at the same institution, specializing in single-cell genomics techniques.
Dr. Sterr's research expertise lies in single-cell genomics, transcriptomics, and epigenetics applied to endocrinogenesis in the pancreas and intestine. His work seeks to decode the molecular mechanisms of endocrine cell specification, which is critical for developing novel diabetes treatments. By characterizing cellular states and reconstructing developmental trajectories, his group provides foundational insights for regenerative medicine.
His recent publications (2021-2022) demonstrate a multidisciplinary approach, integrating single-cell technologies to address questions in diabetes, cancer, and developmental biology. Key themes include β-cell heterogeneity in diabetes, diet-induced alterations in stem cells, and the role of signaling pathways in cell fate decisions. These studies highlight the power of single-cell resolution in uncovering disease mechanisms.
Scientific awards: No specific awards are mentioned in the provided text.
As a group leader, Dr. Sterr is involved in mentoring and grant-funded research. However, the text does not specify his advisees or current grants. His group is supported by institutional affiliations including the German Center for Diabetes Research and Helmholtz AI.
The Single-Cell Genomics Group, led by Dr. Sterr, utilizes cutting-edge single-cell transcriptomic and epigenomic analyses to investigate endocrine lineage decisions. The group is part of the IDR at Helmholtz Munich and collaborates within national and international networks to advance diabetes research.
